Skip to main content
Home
language-selector-globe Sandoz | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | es
Brazil | pt
Canada | en
Canada | fr
Mexico | es
United States | en
Australia | en
Japan | ja
Korea | ko
Mainland China | zh
Austria | de
Belgium | fr
Belgium | nl
Bulgaria | bg
Croatia | hr
Czech Republic | cs
Denmark | da
Finland | fi
France | fr
Germany | de
Hungary | hu
Italy | it
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Slovakia | sk
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
United Kingdom | en
Global | en
Sandoz | en
Saudi Arabia | ar
Turkey | tr
language-selector-globe Sandoz
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | es
Australia | en
Austria | de
Belgium | fr
Belgium | nl
Brazil | pt
Bulgaria | bg
Canada | en
Canada | fr
Croatia | hr
Czech Republic | cs
Denmark | da
Finland | fi
France | fr
Germany | de
Hungary | hu
Italy | it
Japan | ja
Korea | ko
Mainland China | zh
Mexico | es
Netherlands | nl
Norway | no
Global | en
Sandoz | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Saudi Arabia | ar
Slovakia | sk
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
Turkey | tr
United Kingdom | en
United States | en
    • About Sandoz 
      • Our Purpose and Ambition 
      • What We Do 
      • Innovation, Quality and Supply 
      • Corporate Responsibility 
        • Ethics, Risk and Compliance 
        • Sandoz external funding 
        • Malaria Initiative 
        • Novartis Access 
        • World Child Cancer 
      • Our History 
      • Investor Information 
      A girl with a flower About Sandoz
    • Products & Services 
      • Disease Areas 
        • Anti-Infectives 
        • Respiratory 
        • Endocrinology 
        • Immunology 
        • Oncology 
      • Biopharmaceuticals 
        • Value of Biosimilars 
        • Sandoz Biosimilar Portfolio 
        • Sandoz Biosimilar Pipeline 
        • About Biologics 
        • Science of Biosimilars 
        • Information for Patients 
      • Prescription Medicines 
      • Over-The-Counter Medicines 
      • Partnerships and Collaborations 
        • Biotech Cooperations 
        • Business to Business (B2B) 
      00181_300dpi_RGB Products & Services
    • People & Culture 
      • Board of Directors 
      • Sandoz Leadership 
        • Richard Saynor 
        • Francisco Ballester 
        • Martin Bischof 
        • Colin Bond 
        • Pierre Bourdage 
        • Valerie Chew 
        • Claire D'Abreu-Hayling 
        • Glenn A. Gerecke, PhD 
        • Rebecca Guntern 
        • Keren Haruvi 
        • Tripti Jha 
        • Steffen Kurzawa 
        • Ingrid Sollerer 
      • Diversity & Inclusion 
      • Associate Stories 
    • Investors & Media 
      • Sandoz spin-off 
      • Media Releases 
      • Media Library 
      • Media Contacts 
      • Novartis Annual Reporting Suite 
    • Careers 
      • Diversity & Inclusion 
      • Associate Stories 
      • Job Search 
      • Our Teams 
        • Sandoz Technology 
        • Sandoz People & Organization 
      • Personal Growth & Learning at Sandoz 
      • Flexible-Hybrid Working at Sandoz 
      • People & Culture 
      • Diversity & Inclusion 
      • Rewards & Recognition 
      Sandoz Careers Careers
    • News 
      • News Archive 
      • Media Releases 
      • Publications 
      • Stay Up-To-Date 
      A photo of people in a meeting hall News
    • Contacts 
    working at sandoz Home

Sandoz Global

Key resources
  • Patients & Caregivers
  • Job seekers
  • Investors
  • Media
Recent updates
  • Sandoz spin-off
Explore
  • Contacts
  • Locations
  • Biosimilar Portfolio and Pipeline
Sandoz Companies
  • 1A Pharma
  • Hexal
  • Lek
Footer Bottom
© 2023 Sandoz International GmbH
  • Terms of Use
  • Privacy
  • About Cookies
  • Legal Notice
  • Social Media Community Guidelines
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for a global audience